MedTrace Logo

Clonidine is Better Than Zopiclone for Insomnia Treatment in Chronic Pain Patients

NCT05277038 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-11-18

No results posted yet for this study

Summary

A prospective observational crossover study of 160 consenting adult patients who underwent pain management. For insomnia treatment, each patient ingested different prescribed doses of Zopiclone or Clonidine on alternate nights. Each patient used a special validated sleep diary to collect data including pain score, sleep scores, sleep duration, sleep medication dose, and adverse effects. Each patient completed the diary for 3 continuous weeks. Pain was measured using the numeric pain rating scale. Sleep score was measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points was considered significant.

Conditions

  • Insomnia Chronic
  • Pain, Chronic

Interventions

DRUG

Clonidine 0.1mg pill

Routine prescription for insomnia

DRUG

Clonidine 0.2mg pill

Routine prescription for insomnia

DRUG

Zopiclone 3.75mg pill

Routine prescription for insomnia

DRUG

Zopiclone 7.5mg pill

Routine prescription for insomnia

Sponsors & Collaborators

  • Salem Anaesthesia Pain Clinic

    lead OTHER

Principal Investigators

  • Olu Bamgbade, MD, FRCPC · Salem Anaesthesia Pain Clinic

Eligibility

Min Age
20 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2022-11-05
Completion
2022-11-05

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05277038 on ClinicalTrials.gov